Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Cinclus Pharma in a SEK 240 million capital raise backed by Trill Impact

Cinclus Pharma in a SEK 240 million capital raise backed by Trill Impact

Biotech Health services Pharma

Sweden

Ireland

Investments

17 May 2022

Share:

Cinclus Pharma (company)

Sweden

Biotech Health services Pharma

Total investments received (USD): 50.57m

Round value (USD): 24.09m

Round investors: AP4 - Fjärde AP-fonden Eir Ventures Irrus Investments Linc Invest Trill Impact

Company: Cinclus Pharma

Industry: Biotech Health services Pharma

Related deals

Elypta in a $21 million Series A financing round led by Bonnier Ventures.

Biotech Health services

Sweden

Spain

Investments 18 June 2022

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top